Joshua Jennings
Stock Analyst at TD Cowen
(1.46)
# 1735
Out of 5,218 analysts
72
Total ratings
48.00%
Success rate
15.06%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Boston Scientific | Maintains: Strong Buy | 100 110 | 90.16 | 22.01% | 6 | Dec 12, 2024 | |
CeriBell | Maintains: Strong Buy | 31 36 | 29.33 | 22.74% | 2 | Dec 9, 2024 | |
TransMedics Gr | Maintains: Buy | 175 120 | 64.1 | 87.21% | 9 | Nov 18, 2024 | |
Humacyte | Reiterates: Buy | 10 10 | 4.08 | 145.1% | 2 | Oct 18, 2024 | |
Allurion Technologie... | Initiates Coverage On: Buy | 2 | 0.34 | 488.24% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 75 99 | 89.28 | 10.89% | 3 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 143 119 | 106.86 | 11.36% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 55 60 | 57.49 | 4.37% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 83 80 | 72.89 | 9.75% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 3 | 1.1 | 172.73% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 100 70 | 73.33 | -4.54% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 195 185 | 146.69 | 26.12% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 40 | 30.37 | 31.71% | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 365 400 | 375.05 | 6.65% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 60 | 45.77 | 31.09% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 52 34 | 32.68 | 4.04% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 18 | 7.39 | 143.57% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 114 125 | 77.21 | 61.9% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 13 10 | n/a | n/a | 2 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 25 | 17.14 | 45.86% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 130 130 | 113.45 | 14.59% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 7 5 | 2.35 | 112.77% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 360 120 | n/a | n/a | 1 | Jun 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 117 | 82.47 | 41.87% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 450 | 14.2 | 3069.01% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 31 | n/a | n/a | 1 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | n/a | n/a | 1 | Nov 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 12 | 9.63 | 24.61% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 306 275 | 225.62 | 21.89% | 1 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 28 28 | n/a | n/a | 2 | Sep 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 11000 | n/a | n/a | 1 | May 3, 2017 |